Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Targeting Putative Mu Opioid/Chemokine Receptor Type 5 Heteromers Potently Attenuates Nociception in a Murine Model of Sickle Cell Disease

Giuseppe Cataldo, PhD, Mary M. Lunzer, MA, Donald A. Simone, PhD, Eyup Akgün, PhD, John D. Belcher, PhD, Gregory M Vercellotti, Philip S. Portoghese, PhD

Blood (2015) 126 (23): 277.

https://doi.org/10.1182/blood.V126.23.277.277

Published: 2015

Journal Articles

Targeting Nociceptin Receptor to Treat Pain in Sickle Cell Disease

Derek Vang, BS, Lucile Vincent, PhD, Katherine NH Johnson, MS, Nurulaim Zaveri, PhD, Kalpna Gupta

Blood (2012) 120 (21): 373.

https://doi.org/10.1182/blood.V120.21.373.373

Published: 2012

Journal Articles

Characterization of Pain, Vasculature and Innervation in Sickle Cell Disease.

Kalpna Gupta, PhD, Chunsheng Chen, MD, PhD, Marna E. Ericson, PhD, Robert P. Hebbel, MD, Yunfang Li, MD

Blood (2007) 110 (11): 2248.

https://doi.org/10.1182/blood.V110.11.2248.2248

Published: 2007

Journal Articles

Microenvironment-Induced Endothelial Heterogeneity Stimulates Retinal Neovascularization in Sickle Mice.

Kalpna Gupta, PhD, Chunsheng Chen, PhD, Gerard A. Lutty, MD, Robert P. Hebbel, MD

Blood (2006) 108 (11): 1198.

https://doi.org/10.1182/blood.V108.11.1198.1198

Published: 2006

Journal Articles

Opioid Receptors Stimulate Angiogenesis, Lymphangiogenesis and Neurogenesis in Ischemic Wounds in Sickle Mice.

Kalpna Gupta, PhD, Yunfang Li, Nicholas A. Mason, Tou S. Vang, Brett K. Levay-Young, Marna E. Erickson, MD, Robert P. Hebbel, MD

Blood (2006) 108 (11): 1199.

https://doi.org/10.1182/blood.V108.11.1199.1199

Published: 2006

Journal Articles

μ Opioid Receptor Stimulates a Growth Promoting and Pro-Angiogenic Tumor Microenvironment by Transactivating VEGF Receptor-2/Flk-1.

Elliot J. Stephenson, BS, Humberto J. Martinez-Suarez, BS, Mariya Farooqui, MD, Debabrata Mukhopadhyay, PhD, Deborah A. Hughes, MD, Priyabrata Mukherjee, PhD, Kalpna Gupta, PhD

Blood (2005) 106 (11): 3687.

https://doi.org/10.1182/blood.V106.11.3687.3687

Published: 2005

Journal Articles

Morphine Exaggerates Retinopathy in Transgenic Sickle Mice.

Kalpna Gupta, PhD, Chunsheng Chen, MD, PhD, Gerald A. Lutty, PhD, Robert P. Hebbel, MD

Blood (2005) 106 (11): 209.

https://doi.org/10.1182/blood.V106.11.209.209

Published: 2005

Journal Articles

Enhancement of murine bone marrow macrophage differentiation by beta- endorphin

K Hagi, K Inaba, H Sakuta, S Muramatsu

Blood (1995) 86 (4): 1316–1321.

https://doi.org/10.1182/blood.V86.4.1316.bloodjournal8641316

Published: 1995

NARROW

Targeting Putative Mu Opioid/Chemokine Receptor Type 5 Heteromers Potently Attenuates Nociception in a Murine Model of Sickle Cell Disease

Targeting Nociceptin Receptor to Treat Pain in Sickle Cell Disease

Characterization of Pain, Vasculature and Innervation in Sickle Cell Disease.

Microenvironment-Induced Endothelial Heterogeneity Stimulates Retinal Neovascularization in Sickle Mice.

Opioid Receptors Stimulate Angiogenesis, Lymphangiogenesis and Neurogenesis in Ischemic Wounds in Sickle Mice.

μ Opioid Receptor Stimulates a Growth Promoting and Pro-Angiogenic Tumor Microenvironment by Transactivating VEGF Receptor-2/Flk-1.

Morphine Exaggerates Retinopathy in Transgenic Sickle Mice.

Enhancement of murine bone marrow macrophage differentiation by beta- endorphin

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only